{"disease":{"id":"cyanotic-congenital-heart-disease","name":"cyanotic congenital heart disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05800691","title":"Predicting Factors for Mortality in Congenital Heart Disease Patients After Shunt Procedure in Developing Country.","phase":"","overall_status":"COMPLETED","enrollment_count":197,"lead_sponsor_name":"Universitas Sumatera Utara","has_results":false},{"nct_id":"NCT04891081","title":"Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT04125550","title":"Propofol vs Sevoflurane in Cyanotic Congenital Heart Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Cukurova University","has_results":false},{"nct_id":"NCT03678909","title":"Cardiac Biomarkers in Patients With Single Ventricle Physiology","phase":"","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Baylor College of Medicine","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}